References
- 1. Martin GS, Mannino DM, Eaton S, Moss M. The Epidemiology of Sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546-54.10.1056/NEJMoa02213912700374
- 2. Deutschman CS, Tracey KJ. „Sepsis: current dogma and new perspectives”. Immunity 2014; 40 (4): 463–75.10.1016/j.immuni.2014.04.00124745331
- 3. Kaplan JM, Wong HR. Biomarker discovery and development in pediatric critical care medicine. Pediatr Crit Care Med. 2011; 12(2): 165–73.10.1097/PCC.0b013e3181e28876292446220473243
- 4. Feng M, Sun T, Zhao Y, Zhang H. Detection of serum interleukin-6/10/18 levels in sepsis and its clinical significance. J Clin Lab Anal. 2016; DOI:10.1002/jcla.21977.10.1002/jcla.21977680722327184083
- 5. Petilla V, Hynninen M, Takkunen O, Kuusela P, Valtonen M. Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis. Intensive Care Med. 2002; 28(9):1220–5.10.1007/s00134-002-1416-112209268
- 6. Khan A, Ali Z. Normal Ranges for Acute Phase Reactants (Interleukin-6, Tumour Necrosis Factor-alpha and C-reactive Protein) in Umbilical Cord Blood of Healthy Term Neonates at the Mount Hope Women’s Hospital, Trinidad. West Indian Med J. 2014; 63 (5):465-9.
- 7. Georgescu AM, Banescu C, Badea I, et al. IL-6 gene polymorphisms and sepsis in ICU adult romanian patients: a prospective study. Rev Romana Med Lab. 2017;25(1):75–89.10.1515/rrlm-2016-0044
- 8. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JV, Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003; 31(4):1250-6.10.1097/01.CCM.0000050454.01978.3B12682500
- 9. Dellinger RH, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013. Feb;41(2):580-637.10.1097/CCM.0b013e31827e83af23353941
- 10. Pallás Beneyto LA, Rodríguez Luis O, Saiz Sánchez C, Coltell O, Bautista Rentero DB, Bayarri VM. Prognostic Value of Interleukin 6 for Death of Patients With Sepsis. Med Clin. 2016; 147(7):281-6.10.1016/j.medcli.2016.06.00127422737
- 11. Miguel-Bayarri V, Casanoves-Laparra EB, Pallás-Beneyto L, et al. Prognostic value of the biomarkers procalcitonin, interleukin-6 and C-reactive protein in severe sepsis. Med Int. 2012; 36(8):556–62.10.1016/j.medine.2012.10.008
- 12. Gibot S, Cravoisy A, Kolopp-Sarda MN, Béné MC, Faure G, Bollaert PE, Levy B. Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis. Crit Care Med. 2005; 33(4):792-6.10.1097/01.CCM.0000159089.16462.4A
- 13. Khosravani H, Shahpori R, Stelfox HT, Kirkpatrick AW, Laupland KB. Occurrence and adverse effect on outcome of hyperlactatemia in the critically ill. Crit Care. 2009; 13(3):R90.10.1186/cc7918
- 14. Abe T, Suzuki T, Kushimoto S, et al. History of diabetes may delay antibiotic administration in patients with severe sepsis presenting to emergency departments. Medicine (Baltimore). 2020; 99(11):e19446.10.1097/MD.0000000000019446
- 15. Chen CH, Lai CC, Wang YH, Wang CY, Wang HC, Yu CJ, Chen L; Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE). The Impact of Sepsis on the Outcomes of COPD Patients: A Population-Based Cohort Study. J Clin Med. 2018;7 (11):393.10.3390/jcm7110393
- 16. Onal EE, Kitapçi F, Dilmen U, Adam B. Interleukin-6 concentrations in neonatal sepsis. Lancet. 1999; 16(353):239–40.10.1016/S0140-6736(05)77250-0
- 17. Park DW, Chun BC, Kim JM, et al. Epidemiological and clinical characteristics of community-acquired severe sepsis and septic shock: a prospective observational study in 12 university hospitals in Korea. J Korean Med Sci. 2012;27(11):1308-14.10.3346/jkms.2012.27.11.1308349266323166410
- 18. Barre M, Behnes M, Hamed S, et al. Revisiting the Prognostic Value of Monocyte Chemotactic Protein 1 and interleukin-6 in the sepsis-3 Era. J Crit Care. 2018; 43:21-28.10.1016/j.jcrc.2017.08.02428834779
- 19. Naffaa M, Makhoul BF, Tobia A, Kaplan M, Aronson D, Saliba W, Azzam ZS. Interleukin-6 at Discharge Predicts All-Cause Mortality in Patients With Sepsis. Am J Emerg Med 2013; 31(9): 1361-4.10.1016/j.ajem.2013.06.01123896015